HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Inhibition by hydroxy-N-methyl elliptinium of precancerous mammary hyperplastic alveolar nodule formation in mice.

Abstract
Daily subcutaneous injections of 5 micrograms hydroxy-N-methyl elliptinium for 4 weeks in a high mammary tumor strain of SHN virgin mice was found to decrease the number of precancerous mammary hyperplastic alveolar nodules (HAN) associated with the increase in the number of ghosts, the remnants of regressed HAN. On the other hand, the treatment had little influence on the normal mammary lobulo-alveolar system, serum prolactin level, estrous cycle and endocrine organ weights. The results have demonstrated that elliptinium can inhibit the formation of HAN and induce their regression with no modulation of endogenous conditions of mammotropic hormones.
AuthorsH Nagasawa, M Homma, H Namiki, K Niki
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 20 Issue 2 Pg. 273-6 (Feb 1984) ISSN: 0277-5379 [Print] ENGLAND
PMID6538491 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Antineoplastic Agents
  • Ellipticines
  • elliptinium
  • Prolactin
Topics
  • Alkaloids (therapeutic use)
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Body Weight (drug effects)
  • Ellipticines (therapeutic use)
  • Endocrine Glands (drug effects)
  • Estrus (drug effects)
  • Female
  • Hyperplasia (prevention & control)
  • Mammary Neoplasms, Experimental (physiopathology, prevention & control)
  • Mice
  • Mice, Inbred Strains
  • Organ Size (drug effects)
  • Precancerous Conditions (physiopathology, prevention & control)
  • Pregnancy
  • Prolactin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: